PanGenex Corporation Provides Dividend Update
PanGenex Corporation (Pink Sheets:PGCX – News), a global nutraceutical and dietary supplement manufacturer and marketer, announced today that the previously announced (December 7, 2009) one for ten stock dividend is being processed and pending regulatory approval, the pay date for such issuance should be on or about February 1, 2010. The Company’s announcement of the stock dividend was for shareholders of record as of January 8, 2010. Such shares are being requested for delivery from the Company’s Transfer Agent, Manhattan Transfer Registrar Company.
About PanGenex Corporation
PanGenex Corporation pursues business opportunities in the $70 billion nutraceutical and dietary supplement industry. With a focus on the cardiovascular health segment, PanGenex develops and markets sector-leading, patented or patent pending, condition-specific nutraceuticals and topical over-the-counter (OTC) drugs and personal care products. Many of its products contain the purest grade of nutraceutical components available anywhere without a prescription. Since 2006, PanGenex has voluntarily submitted its product labels to the FDA without incidence. PanGenex products are sold to healthcare practitioners in 20 U.S. states, Canada, Puerto Rico, Brazil and Australia, in fine retail establishments and on the Internet including: www.PanGenex.com, www.Calgenex.com and www.HeartHealthyWorld.com.